Summary: The Prescription Your Phone Can Write
AI, the Body After 60, and the Tools That Actually Exist
Linda’s kitchen table holds seven prescription bottles from three pharmacies. Last month she ended up in the emergency room from a doubled blood pressure dose after her cardiologist adjusted it and her primary care physician had not yet received the note. No one owns the view from Linda’s table, where all seven medications exist at the same time.
Nearly half of adults over 65 take five or more prescriptions, and the problems compound in ways no single prescriber is positioned to catch. The structural problem: no one is paid to see the whole patient. What exists now is more useful than most people realize. Smart pill dispensers ($60 to $800) significantly reduce missed and doubled doses. Medication management apps like Medisafe offer free interaction checks. Most importantly, Medicare Part D includes Medication Therapy Management: a free comprehensive medication review by a pharmacist for those taking eight or more chronic medications with three or more qualifying conditions. Roughly two-thirds of eligible beneficiaries never receive it. One phone call to your Part D plan can fix that.
Remote Patient Monitoring is expanding. The ACCESS model, scheduled for broader implementation in July 2026, is Medicare’s most significant RPM expansion. A 2023 Cochrane review found RPM reduced heart failure hospitalizations by roughly 20 percent. The caveat: monitoring requires a clinical team with capacity to review data and act on it.
Fall detection devices achieve 70 to 90 percent accuracy for genuine falls, with false positive rates that cause some people to stop wearing them. Ambient radar-based systems avoid the wearability problem but introduce privacy trade-offs. The most effective fall intervention remains the one that prevents the fall: strength and balance training, medication review, home hazard assessment.
On the two-to-three year horizon: ambient radar detecting gait changes months before a fall, AI-powered gait analysis from smartphone cameras, and expanding continuous glucose monitoring. Linda called her Part D plan, found she was eligible for MTM, and has an appointment with a pharmacist next Tuesday. The gap that matters most is between what already exists and the people who need it.